At-home genetic testing for cancer and other disease risk is booming: Should you try it?
By A. Pawlowski,
Today
| 10. 04. 2021
Breast Cancer Awareness Month will cause many women to worry about their hereditary risk for developing the disease, especially if it runs in their family.
Genetic testing can answer that piece of the puzzle for breast and many other types of cancer, as well as a variety of diseases. It used to be costly, and require doctor’s orders and appointments. But anyone can now buy a fairly inexpensive DNA testing kit online and receive some answers without leaving home as part of a growing industry known as direct-to-consumer genetic testing.
How it works:
It usually means providing a saliva sample and sending it back to the company for lab analysis, with the results accessible via a secure online portal or sent in a letter. Depending on the company, a physician doesn’t necessarily have to be involved to order the kit or get the findings.
Proponents say it democratizes the process, giving people more access to their genetic information and allowing them to take action to protect their health. But experts also worry about the tests’ validity and false reassurance, and...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...